Photodynamic Therapy Then & Now: Current Concepts for Real-World Use

CME WEBINAR BROADCAST | JUNE 28, 2019 | 8 PM EST

Verteporfin for photodynamic therapy (PDT) has been approved for decades as a treatment for retinal disorders. Eye care professionals need to understand all the real-world clinical scenarios in which the use of PDT alone or in combination with anti-VEGF therapy can be a more efficacious treatment option than anti-VEGF monotherapy.

Direct Link: EVOLVEMED

Is photodynamic therapy still useful? The image above is a case of a 49 year old with a peripapillary lesion and macular edema treated with a single application of PDT. From left to right is the result over 6 months.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close